Loading, please wait...
The goal of this presentation is to provide pharmacist and technicians with information on how buprenorphine can be used to treat pain.
***Please note: this course is 1 hour of CE credit***
To access the video after registration, please click the "+" sign to the left of the program title listed below in light blue.
CE Hours
2.00
CE Units
0.200
Activity Type
- Application
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
Texas Tech University Health Sciencies Center Jerry H. Hodge School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
To receive credit you must watch the recorded webinar and complete the post-test. You must receive a minumum of 70% on the post-test at which time you will be prompted to complete a program evaluation form.
|
Please choose a Fee Type from the Drop Down Menu Below:
I am a
|
Objectives
- Discuss the pharmacology of buprenorphine
- Compare and Contrast formulations of buprenorphine
- Discuss the scheduling and prescribing regulations for buprenorphine
- Devise a plan for a chronic pain using buprenorphine
Speaker(s)/Author(s)
|
Nakia A. Duncan, Pharm D, BCGP, BCPS Brief Bio : Nakia Duncan, Pharm.D. BCGP, BCPS is an Assistant Professor of Geriatric Pharmacy Practice at the Texas Tech University Health Sciences Center School of Pharmacy on the Dallas/Fort Worth campus with an affiliated practice with UT Southwestern. There she focuses on symptom and supportive care on the palliative care team. She is also a core preceptor for the ASHP-accredited PGY2 Geriatric Pharmacotherapy residency. She earned her Doctor of Pharmacy degree from Hampton University in 2010 and went on to complete a pharmacy practice residency in New Orleans, LA and a specialty residency in geriatric pharmacotherapy in Baltimore, MD. Her practice and research interests include pain and palliative care management of older adults. She is the author several peer-reviewed publications and has been asked to speak on various geriatrics-focused topics at both Local and National meetings. She is a member of the American Society of Consultant Pharmacists and the Secretary/Treasurer of the Texas chapter of ASCP Board. She is also an active member of the American College of Clinical Pharmacy and American Society of Health-Systems Pharmacists. Disclosure : The presenter has no relevant conflict of interest related to this presentation. The speaker has no relevant financial relationship(s) with ineligible companies to disclose with regard to this presentation. |
Activity Number
0096-0000-22-058-H08-P
Release Date:
Mar 9, 2022
Credit Expiration Date:
Mar 9, 2025
CE Hours
1.00
Fee
$10.00
Objectives
- Discuss the pharmacology of buprenorphine
- Compare and Contrast formulations of buprenorphine
- Discuss the scheduling and prescribing regulations for buprenorphine
Speaker(s)/Author(s)
|
Nakia A. Duncan, Pharm D, BCGP, BCPS Brief Bio : Nakia Duncan, Pharm.D. BCGP, BCPS is an Assistant Professor of Geriatric Pharmacy Practice at the Texas Tech University Health Sciences Center School of Pharmacy on the Dallas/Fort Worth campus with an affiliated practice with UT Southwestern. There she focuses on symptom and supportive care on the palliative care team. She is also a core preceptor for the ASHP-accredited PGY2 Geriatric Pharmacotherapy residency. She earned her Doctor of Pharmacy degree from Hampton University in 2010 and went on to complete a pharmacy practice residency in New Orleans, LA and a specialty residency in geriatric pharmacotherapy in Baltimore, MD. Her practice and research interests include pain and palliative care management of older adults. She is the author several peer-reviewed publications and has been asked to speak on various geriatrics-focused topics at both Local and National meetings. She is a member of the American Society of Consultant Pharmacists and the Secretary/Treasurer of the Texas chapter of ASCP Board. She is also an active member of the American College of Clinical Pharmacy and American Society of Health-Systems Pharmacists. Disclosure : The presenter has no relevant conflict of interest related to this presentation. The speaker has no relevant financial relationship(s) with ineligible companies to disclose with regard to this presentation. |
Activity Number
0096-0000-22-058-H08-T
Release Date:
Mar 9, 2022
Credit Expiration Date:
Mar 9, 2025
CE Hours
1.00
Fee
$10.00